ONCOLOGY LIQUID INJECTABLES

ONCOLOGY LIQUID INJECTABLES

Products
ONCOLOGY LIQUID INJECTABLES
ONCOLOGY LIQUID INJECTABLES

Information

CARBOPLATIN | CISPLATIN | CYTARABINE LIQUID | DOCETAXEL WITH SOLVENT | DOCETAXEL (CTD) SINGLE VIAL | DOXORUBICIN | EPIRUBICINE | ETOPOSIDE | IRINOTECAN | LEUCOVORIN CALCIUM | METHOTREXATE | OXALIPLATIN | PLERIXAFOR | PACLITAXEL | VINCRISTINE | 5-FLOUROURACIL | FULVESTRANT
Distribution Areas
North America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
GermanyIndia
All categories
Finished Dosage FormsInjectablesProducts
Main Categories
Finished Dosage Forms
Venus Remedies Limited/ Venus Pharma GmbHVenus Remedies Limited; the parent company of Venus Pharma GmbH, globally recognized for their unwavering commitment to quality and innovation, proudly holds EU-GMP certification in injectable manufacturing, a testament to their world-class manufacturing standards. With a vast global footprint spanning 70 countries, our reputation is underpinned by 20+ distinguished accreditations. Our portfolio boasts 900+ Marketing Authorizations, reinforcing our expertise & dedication to innovation!

Log in

See all the content and easy-to-use features by logging in or registering!